ACCD - Accolade, Inc.

QQQ $ 454.82 $ -8.72 (-1.89 %)

DIA $ 398.57 $ -6.66 (-1.68 %)

SPY $ 530.36 $ -8.01 (-1.5 %)

TLT $ 91.26 $ -0.62 (-0.68 %)

GLD $ 225.37 $ -3.02 (-1.38 %)

Previous Close

$ 7.32

Open

$ 7.21

Bid

$ 7.05 x 100

Ask

$ 7.08 x 124

Day's Range

$ 7.04 - $ 7.33

52 Week Range

$ 6.33 - $ 15.36

Volume

393,286

Average Volume

Market Cap

548.32M

Beta (5Y Monthly)

$ 2.13

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	04-25-2024	02-29-2024	10-K
2	01-08-2024	11-30-2023	10-Q
3	10-04-2023	08-31-2023	10-Q
4	06-29-2023	05-31-2023	10-Q
5	04-28-2023	02-28-2023	10-K
6	01-09-2023	11-30-2022	10-Q
7	10-06-2022	08-31-2022	10-Q
8	07-01-2022	05-31-2022	10-Q
9	05-02-2022	02-28-2022	10-K
10	01-11-2022	11-30-2021	10-Q
11	10-07-2021	08-31-2021	10-Q
12	07-08-2021	05-31-2021	10-Q
13	05-07-2021	02-28-2021	10-K
14	01-07-2021	11-30-2020	10-Q
15	10-14-2020	08-31-2020	10-Q
16	08-13-2020	05-31-2020	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Guggenheim Maintains Buy on Accolade, Lowe...
05/08/2024 17:25:12

Guggenheim analyst Sandy Draper maintains Accolade (NASDAQ:ACCD) with a Buy and lowers the price target from $17 to $13.

Wells Fargo Maintains Equal-Weight on Acco...
04/30/2024 14:50:00

Wells Fargo analyst Stan Berenshteyn maintains Accolade (NASDAQ:ACCD) with a Equal-Weight and lowers the price target from $...

12-health-care-stocks-moving-in-fridays-after-market-session

12 Health Care Stocks Moving In Friday's A...
04/26/2024 20:31:15

Why Aon Shares Are Trading Lower By Around...
04/26/2024 17:56:57

Morgan Stanley Maintains Equal-Weight on A...
04/26/2024 16:33:21

Morgan Stanley analyst Ricky Goldwasser maintains Accolade (NASDAQ:ACCD) with a Equal-Weight and lowers the price target fro...

12-health-care-stocks-moving-in-fridays-intraday-session

12 Health Care Stocks Moving In Friday's I...
04/26/2024 16:31:22

Truist Securities Maintains Buy on Accolad...
04/26/2024 15:37:28

Truist Securities analyst Jailendra Singh maintains Accolade (NASDAQ:ACCD) with a Buy and lowers the price target from $16 t...

Canaccord Genuity Maintains Buy on Accolad...
04/26/2024 12:46:35

Canaccord Genuity analyst Richard Close maintains Accolade (NASDAQ:ACCD) with a Buy and lowers the price target from $18 to ...

Barclays Maintains Equal-Weight on Accolad...
04/26/2024 11:43:47

Barclays maintains Accolade (NASDAQ:ACCD) with a Equal-Weight and lowers the price target from $13 to $11.

Needham Maintains Buy on Accolade, Lowers ...
04/26/2024 10:37:47

Needham analyst Ryan MacDonald maintains Accolade (NASDAQ:ACCD) with a Buy and lowers the price target from $17 to $13.

Accolade Sees Q1 Revenue $103M-$106M vs $1...
04/25/2024 20:41:55

Accolade Q4 2024 GAAP EPS $(0.10) Beats $(...
04/25/2024 20:07:36

Accolade (NASDAQ:ACCD) reported quarterly losses of $(0.10) per share which beat the analyst consensus estimate of $(0.12) by 1...

Alphabet To Rally Around 14%? Here Are 10 ...
04/22/2024 12:32:56

Stifel Maintains Buy on Accolade, Lowers P...
04/22/2024 11:32:06

Stifel analyst David Grossman maintains Accolade (NASDAQ:ACCD) with a Buy and lowers the price target from $15 to $13.

Accolade Stock: A Deep Dive Into Analyst P...
02/26/2024 19:01:48

Leerink Partners Initiates Coverage On Acc...
02/26/2024 12:48:51

Leerink Partners analyst Michael Cherny initiates coverage on Accolade (NASDAQ:ACCD) with a Outperform rating and announces ...

A Glimpse Into The Expert Outlook On Accol...
01/19/2024 12:01:02

Needham Reiterates Buy on Accolade, Mainta...
01/19/2024 11:48:01

Needham analyst Ryan MacDonald reiterates Accolade (NASDAQ:ACCD) with a Buy and maintains $17 price target.

Nasdaq Edges Higher; Cutera Shares Jump
01/09/2024 20:10:04

U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite turning higher on Tuesday. The Dow traded down 0...

Truist Securities Maintains Buy on Accolad...
01/09/2024 19:33:45

Truist Securities analyst Jailendra Singh maintains Accolade (NASDAQ:ACCD) with a Buy and raises the price target from $15 t...